{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioinformatics", "breast cancer", "medicinal plants", "metastasis", "triple-negative breast cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34944840", "DateRevised": {"Year": "2021", "Month": "12", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "10"}], "Language": ["eng"], "ELocationID": ["6222", "10.3390/cancers13246222"], "Journal": {"ISSN": "2072-6694", "JournalIssue": {"Volume": "13", "Issue": "24", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "10"}}, "Title": "Cancers", "ISOAbbreviation": "Cancers (Basel)"}, "ArticleTitle": "Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and <i>In Silico</i> Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview.", "Abstract": {"AbstractText": ["Cancer is one of the most common malignant diseases that occur worldwide, among which breast cancer is the second leading cause of death in women. The subtypes are associated with differences in the outcome and were selected for treatments according to the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor. Triple-negative breast cancer, one of the subtypes of breast cancer, is difficult to treat and can even lead to death. If breast cancer is not treated during the initial stages, it may spread to nearby organs, a process called metastasis, through the blood or lymph system. For in vitro studies, MCF-7, MDA-MB-231, MDA-MB-468, and T47B are the most commonly used breast cancer cell lines. Clinically, chemotherapy and radiotherapy are usually expensive and can also cause side effects. To overcome these issues, medicinal plants could be the best alternative for chemotherapeutic drugs with fewer side effects and cost-effectiveness. Furthermore, the genes involved in breast cancer can be regulated and synergized with signaling molecules to suppress the proliferation of breast cancer cells. In addition, nanoparticles encapsulating (nano-encapsulation) medicinal plant extracts showed a significant reduction in the apoptotic and cytotoxic activities of breast cancer cells. This present review mainly speculates an overview of the native medicinal plant derived anti-cancerous compounds with its efficiency, types and pathways involved in breast cancer along with its genes, the mechanism of breast cancer brain metastasis, chemoresistivity and its mechanism, bioinformatics approaches which could be an effective alternative for drug discovery."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Sri Shakthi Institute of Engineering and Technology, Coimbatore 641062, Tamil Nadu, India."}], "LastName": "Shrihastini", "ForeName": "Vijayakumar", "Initials": "V"}, {"Identifier": ["0000-0001-7294-1625"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Sri Shakthi Institute of Engineering and Technology, Coimbatore 641062, Tamil Nadu, India."}], "LastName": "Muthuramalingam", "ForeName": "Pandiyan", "Initials": "P"}, {"Identifier": ["0000-0002-7064-7534"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Science Campus, Alagappa University, Karaikudi 630003, Tamil Nadu, India."}], "LastName": "Adarshan", "ForeName": "Sivakumar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Sri Shakthi Institute of Engineering and Technology, Coimbatore 641062, Tamil Nadu, India."}], "LastName": "Sujitha", "ForeName": "Mariappan", "Initials": "M"}, {"Identifier": ["0000-0002-3540-4449"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, National University of Kaohsiung, Kaohsiung 811, Taiwan."}], "LastName": "Chen", "ForeName": "Jen-Tsung", "Initials": "JT"}, {"Identifier": ["0000-0002-2167-4843"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Horticultural Sciences, Gyeongsang National University, Jinju 52725, Korea."}], "LastName": "Shin", "ForeName": "Hyunsuk", "Initials": "H"}, {"Identifier": ["0000-0002-7969-4935"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Science Campus, Alagappa University, Karaikudi 630003, Tamil Nadu, India."}], "LastName": "Ramesh", "ForeName": "Manikandan", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cancers (Basel)", "NlmUniqueID": "101526829", "ISSNLinking": "2072-6694"}, "CoiStatement": "Authors have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Petrovska B.B. Historical review of medicinal plants\u2019 usage. Pharmacogn. Rev. 2012;6:1\u20135. doi: 10.4103/0973-7847.95849.", "ArticleIdList": ["10.4103/0973-7847.95849", "PMC3358962", "22654398"]}, {"Citation": "Cosme P., Rodr\u00edguez A.B., Espino J., Garrido M. Plant phenolics: Bioavailability as a key determinant of their potential health-promoting applications. Antioxidants. 2020;9:1263. doi: 10.3390/antiox9121263.", "ArticleIdList": ["10.3390/antiox9121263", "PMC7764680", "33322700"]}, {"Citation": "Linnewiel-Hermoni K., Khanin M., Danilenko M., Zango G., Amosi Y., Levy J., Sharoni Y. The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity. Arch. Biochem. Biophys. 2015;572:28\u201335. doi: 10.1016/j.abb.2015.02.018.", "ArticleIdList": ["10.1016/j.abb.2015.02.018", "25711533"]}, {"Citation": "Habli Z., Toumieh G., Fatfat M., Rahal O.N., Gali-Muhtasib H. Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms. Molecules. 2017;22:250. doi: 10.3390/molecules22020250.", "ArticleIdList": ["10.3390/molecules22020250", "PMC6155614", "28208712"]}, {"Citation": "Nagai H., Kim Y.H. Cancer prevention from the perspective of global cancer burden patterns. J. Thorac. Dis. 2017;9:448. doi: 10.21037/jtd.2017.02.75.", "ArticleIdList": ["10.21037/jtd.2017.02.75", "PMC5394024", "28449441"]}, {"Citation": "Kondov B., Milenkovikj Z., Kondov G., Petrushevska G., Basheska N., Bogdanovska-Todorovska M., Tolevska N., Ivkovski L. Presentation of the Molecular Subtypes of Breast Cancer Detected by Immunohistochemistry in Surgically Treated Patients. Open Access Maced. J. Med. Sci. 2018;6:961\u2013967. doi: 10.3889/oamjms.2018.231.", "ArticleIdList": ["10.3889/oamjms.2018.231", "PMC6026408", "29983785"]}, {"Citation": "Redig A.J., McAllister S.S. Breast cancer as a systemic disease: A view of metastasis. J. Intern. Med. 2013;274:113\u2013126. doi: 10.1111/joim.12084.", "ArticleIdList": ["10.1111/joim.12084", "PMC3711134", "23844915"]}, {"Citation": "Cordero M.J.A., Villar N.M., S\u00e1nchez M.N., Pimentel-Ram\u00edrez M.L., Garc\u00eda-Rillo A., Valverde E.G. Breast cancer and body image as a prognostic factor of depression: A case study in M\u00e9xico City. Nutr Hosp. 2015;31:371\u2013379.", "ArticleIdList": ["25561132"]}, {"Citation": "Pan S.Y., Zhou S.F., Gao S.H., Yu Z.L., Zhang S.F., Tang M.K., Sun J.N., Ma D.L., Han Y.F., Fong W.F., et al. New perspectives on how to discover drugs from herbal medicines: CAM\u2019s outstanding contribution to modern therapeutics. Evid. Based Complement. Alternat. Med. 2013;2013:5\u201312. doi: 10.1155/2013/627375.", "ArticleIdList": ["10.1155/2013/627375", "PMC3619623", "23634172"]}, {"Citation": "Laskar Y.B., Lourembam R.M., Mazumder P.B. Medicinal Plants\u2014Use in Prevention and Treatment of Diseases. InTech Open; London, UK: 2020. Herbal remedies for breast cancer prevention and treatment. Chapter 3."}, {"Citation": "Li Y., Li S., Meng X., Gan R.Y., Zhang J.J., Li H.B. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients. 2017;9:728. doi: 10.3390/nu9070728.", "ArticleIdList": ["10.3390/nu9070728", "PMC5537842", "28698459"]}, {"Citation": "Solowey E., Lichtenstein M., Sallon S., Paavilainen H., Solowey E., Lorberboum-Galski H. Evaluating medicinal plants for anticancer activity. Sci. World J. 2014;2014:1\u201312. doi: 10.1155/2014/721402.", "ArticleIdList": ["10.1155/2014/721402", "PMC4248331", "25478599"]}, {"Citation": "Moshiri M., Hamid F., Etemad L. Ricin toxicity: Clinical and molecular aspects. Rep. Biochem. Mol. 2016;4:60.", "ArticleIdList": ["PMC4986263", "27536698"]}, {"Citation": "Leitzmann M., Powers H., Anderson A.S., Scoccianti C., Berrino F., Boutron-Ruault M.C., Cecchini M., Espina C., Key J.T., Norat T., et al. European code against cancer 4th Edition: Physical activity and cancer. Cancer. Epidemiol. 2015;39:S46\u2013S55. doi: 10.1016/j.canep.2015.03.009.", "ArticleIdList": ["10.1016/j.canep.2015.03.009", "26187327"]}, {"Citation": "Sharma V., Sarkar I.N. Bioinformatics opportunities for identification and study of medicinal plants. Brief. Bioinform. 2013;14:238\u2013250. doi: 10.1093/bib/bbs021.", "ArticleIdList": ["10.1093/bib/bbs021", "PMC3603214", "22589384"]}, {"Citation": "Cui Z.J., Gao M., Quan Y., Lv B.M., Tong X.Y., Dai T.F., Zhou X.H., Zhang H.Y. Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer. Cancers. 2021;13:3586. doi: 10.3390/cancers13143586.", "ArticleIdList": ["10.3390/cancers13143586", "PMC8305788", "34298802"]}, {"Citation": "Wishart D.S. Current Protoc Bioinformatics. Introduction to Cheminformatics. Volume 14. John Wiley & Sons; Edmonton, AB, Canada: 2007. pp. 1\u20139."}, {"Citation": "Carey L.A. Through a glass darkly: Advances in understanding breast cancer biology, 2000\u20132010. Clin. Breast Cancer. 2010;10:188\u2013195. doi: 10.3816/CBC.2010.n.026.", "ArticleIdList": ["10.3816/CBC.2010.n.026", "20497917"]}, {"Citation": "Shao M.M., Chan S.K., Yu A.M., Lam C.C., Tsang J.Y., Lui P.C., Law B.K., Tan P.H., Tse G.M. Keratin expression in breast cancers. Virchows Arch. 2012;461:313\u2013322. doi: 10.1007/s00428-012-1289-9.", "ArticleIdList": ["10.1007/s00428-012-1289-9", "22851038"]}, {"Citation": "Yersal O., Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World. J. Clin. Oncol. 2014;5:412\u2013424. doi: 10.5306/wjco.v5.i3.412.", "ArticleIdList": ["10.5306/wjco.v5.i3.412", "PMC4127612", "25114856"]}, {"Citation": "Jia R., Li Z., Liang W. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis. World. J. Surg. Oncol. 2020;18:268. doi: 10.1186/s12957-020-02042-z.", "ArticleIdList": ["10.1186/s12957-020-02042-z", "PMC7568373", "33066779"]}, {"Citation": "Rakha E.A., Elsheiskh S.E., Aleskandarany M.A., Habashi H.O., Green A.R., Powe D.G., El-Sayed M.E., Benhasouna A., Brunet J.S., Akslen L.A., et al. Triple-negative breast cancer: Distinguish between basal and non-basal subtypes. Clin. Cancer Res. 2009;15:2302\u20132310. doi: 10.1158/1078-0432.CCR-08-2132.", "ArticleIdList": ["10.1158/1078-0432.CCR-08-2132", "19318481"]}, {"Citation": "Alluri P., Newman L.A. Basal-like and triple-negative breast cancers: Searching for positives among many negatives. Surg. Oncol. Clin. N. Am. 2014;23:567\u2013577. doi: 10.1016/j.soc.2014.03.003.", "ArticleIdList": ["10.1016/j.soc.2014.03.003", "PMC4304394", "24882351"]}, {"Citation": "Kreike B., van Kouwenhove M., Horlings H., Weigelt B., Peterse H., Bartelink H., van de Vijer M.J. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res. 2007;9:65. doi: 10.1186/bcr1771.", "ArticleIdList": ["10.1186/bcr1771", "PMC2242660", "17910759"]}, {"Citation": "Kumar P., Aggarwal R. An overview of triple-negative breast cancer. Arch. Gynecol. Obset. 2016;15:3859. doi: 10.1007/s00404-015-3859-y.", "ArticleIdList": ["10.1007/s00404-015-3859-y", "26341644"]}, {"Citation": "Schettini F., Prat A. Dissecting the biological heterogeneity of HER2-positive breast cancer. Breast. 2021;59:339\u2013350. doi: 10.1016/j.breast.2021.07.019.", "ArticleIdList": ["10.1016/j.breast.2021.07.019", "PMC8374722", "34392185"]}, {"Citation": "Yin L., Duan J.J., Bian X.W., Yi S.C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22:61. doi: 10.1186/s13058-020-01296-5.", "ArticleIdList": ["10.1186/s13058-020-01296-5", "PMC7285581", "32517735"]}, {"Citation": "Bose S., Chandran S., Mirocha J., Bose N. The Akt pathway in human breast cancer: A tissue-array-based analysis. Mod. Pathol. 2006;19:238\u2013245. doi: 10.1038/modpathol.3800525.", "ArticleIdList": ["10.1038/modpathol.3800525", "16341149"]}, {"Citation": "Zakikhani M., Blouin M.J., Piura E., Pollak M.N. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res. Treat. 2010;123:271\u2013279. doi: 10.1007/s10549-010-0763-9.", "ArticleIdList": ["10.1007/s10549-010-0763-9", "20135346"]}, {"Citation": "Wang W., Eddy R., Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nature Rev. Cancer. 2007;7:429\u2013440. doi: 10.1038/nrc2148.", "ArticleIdList": ["10.1038/nrc2148", "PMC4270061", "17522712"]}, {"Citation": "Hui M., Cazet A., Nair R., Watkins D.N., O\u2019Toole S.A., Swarbrick A. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Res. 2013;15:203. doi: 10.1186/bcr3401.", "ArticleIdList": ["10.1186/bcr3401", "PMC3672663", "23547970"]}, {"Citation": "Habib J.G., O\u2019Shaughnessy J.A. The hedgehog pathway in triple-negative breast cancer. Cancer Med. 2016;5:2989\u20133006. doi: 10.1002/cam4.833.", "ArticleIdList": ["10.1002/cam4.833", "PMC5083752", "27539549"]}, {"Citation": "Kubo M., Nakamura M., Tasaki A., Yamanaka N., Nakashima H., Nomura M., Kuroki S., Katano M. Hedghog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res. 2004;64:6071\u20136074. doi: 10.1158/0008-5472.CAN-04-0416.", "ArticleIdList": ["10.1158/0008-5472.CAN-04-0416", "15342389"]}, {"Citation": "Souzaki M., Kubo M., Kai M., Kameda C., Tanaka H., Taguchi T., Tanaka M., Onishi H., Katano M. Hedgehog sinnaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci. 2011;102:373\u2013381. doi: 10.1111/j.1349-7006.2010.01779.x.", "ArticleIdList": ["10.1111/j.1349-7006.2010.01779.x", "21091847"]}, {"Citation": "Zhou Y., Eppenberger-Castori S., Eppenberger U., Benz C.C. The NF\u03baB pathway and endocrine-resistant breast cancer. Endocr. Relat. Cancer. 2005;12:S37\u2013S46. doi: 10.1677/erc.1.00977.", "ArticleIdList": ["10.1677/erc.1.00977", "16113098"]}, {"Citation": "Zhou J., Zhang H., Gu P., Bai J., Margolick J.B., Zhang Y. NF\u03baB pathway inhibitors referentially inhibit breast cancer stem-like cells. Breast Cancer Res. Treat. 2008;111:419\u2013427. doi: 10.1007/s10549-007-9798-y.", "ArticleIdList": ["10.1007/s10549-007-9798-y", "PMC3320112", "17965935"]}, {"Citation": "Gong L., Li Y., Nedeljkovic-Kurepa A., Sarkar S.H. Inactivation of NF\u03baB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene. 2003;22:4702\u20134709. doi: 10.1038/sj.onc.1206583.", "ArticleIdList": ["10.1038/sj.onc.1206583", "12879015"]}, {"Citation": "Cidado J., Park B.H. Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy. J. Mammary Gland Biol. Neoplasia. 2012;17:205\u2013216. doi: 10.1007/s10911-012-9264-2.", "ArticleIdList": ["10.1007/s10911-012-9264-2", "PMC3724399", "22865098"]}, {"Citation": "L\u00f3pez-Knowles E., O\u2019Toole S.A., McNeil C.M., Millar E.K., Qiu M.R., Crea P., Daly R.J., Musgrove E.A., Sutherland R.L. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int. J. Cancer. 2010;126:1121\u20131131. doi: 10.1002/ijc.24831.", "ArticleIdList": ["10.1002/ijc.24831", "19685490"]}, {"Citation": "Pascual J., Turner N.C. Targeting the PI3-kinase pathway in triple-negative breast cancer. Ann. Oncol. 2019;1:1\u201310. doi: 10.1093/annonc/mdz133.", "ArticleIdList": ["10.1093/annonc/mdz133", "31050709"]}, {"Citation": "Paplomata E., O\u2019Regan R. The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers. Ther. Adv. Med. Oncol. 2014;6:154\u2013166. doi: 10.1177/1758834014530023.", "ArticleIdList": ["10.1177/1758834014530023", "PMC4107712", "25057302"]}, {"Citation": "Yang S.X., Polley E., Lipkowitz S. New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treat. Rev. 2016;45:87\u201396. doi: 10.1016/j.ctrv.2016.03.004.", "ArticleIdList": ["10.1016/j.ctrv.2016.03.004", "PMC7436195", "26995633"]}, {"Citation": "Chandarlapaty S., Sakr R.A., Giri D. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clin. Cancer Res. 2012;18:6784\u20136791. doi: 10.1158/1078-0432.CCR-12-1785.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-1785", "PMC3525734", "23092874"]}, {"Citation": "Pierobon M., Ramos C., Wong S., Alex Hodge K., Aldrich J., Byron S., Anthony S.P., Robert N.J., Northfelt D.W., Jahanzeb M., et al. Enrichment of PI3K-AKT\u2013mTOR Pathway Activation in Hepatic Metastases from Breast Cancer. Clin. Cancer Res. 2017;23:16. doi: 10.1158/1078-0432.CCR-16-2656.", "ArticleIdList": ["10.1158/1078-0432.CCR-16-2656", "PMC5564311", "28446508"]}, {"Citation": "Ghayad S.E., Cohen P.A. Inhibitors of the PI3K/Akt/mTOR pathway: New hope for breast cancer patients. Recent Pat. Anticancer Drug Discov. 2010;5:29\u201357. doi: 10.2174/157489210789702208.", "ArticleIdList": ["10.2174/157489210789702208", "19751211"]}, {"Citation": "Gil E.M.C. Targeting the PI3K/Akt/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat. Rev. 2014;40:862\u2013871.", "ArticleIdList": ["24774538"]}, {"Citation": "Mohinta S., Wu H., Chaurasia P., Watbe K. Wnt pathway and breast cancer. Front. Biosci. 2007;12:4020\u20134033. doi: 10.2741/2368.", "ArticleIdList": ["10.2741/2368", "17485355"]}, {"Citation": "Mukherjee N., Battacharya N., Alam N., Roy A., Roychoudhury S., Panda C.K. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: Clinical and prognostic significance. Cancer Sci. 2012;103:210\u2013220. doi: 10.1111/j.1349-7006.2011.02131.x.", "ArticleIdList": ["10.1111/j.1349-7006.2011.02131.x", "22026417"]}, {"Citation": "Loh Y.N., Hedditch E.L., Baker L.A., Jary E., Ward R.L., Ford C.E. The Wnt signaling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. BMC Cancer. 2013;13:174. doi: 10.1186/1471-2407-13-174.", "ArticleIdList": ["10.1186/1471-2407-13-174", "PMC3621642", "23547709"]}, {"Citation": "Voduc K.D., Nielsen T.O., Perou C.M., Harrell J.C., Fan C., Kennecke H., Minn A.J., Cryns V.L., Cheang M.C. \u03b1B-crystallin expression in breast cancer is associated with brain metastasis. npj Breast Cancer. 2015;1:15014. doi: 10.1038/npjbcancer.2015.14.", "ArticleIdList": ["10.1038/npjbcancer.2015.14", "PMC5027912", "27656679"]}, {"Citation": "Boral D., Vishnoi M., Liu H.N., Yin W., Sprouse M.L., Scamardo A., Hong D.S., Tan T.Z., Thiery J.P., Chang J.C., et al. Molecular characterization of breast cancer CTCs associated with brain metastasis. Nat. Commun. 2017;8:196. doi: 10.1038/s41467-017-00196-1.", "ArticleIdList": ["10.1038/s41467-017-00196-1", "PMC5543046", "28775303"]}, {"Citation": "Chung B., Esmaeili A.A., Gopalakrishna-Pillai S., Murad J.P., Andersen E.S., Reddy N.K., Srinivasan G., Armstrong B., Chu C., Kim Y., et al. Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. npj Breast Cancer. 2017;2017:6. doi: 10.1038/s41523-017-0008-8.", "ArticleIdList": ["10.1038/s41523-017-0008-8", "PMC5460196", "28649646"]}, {"Citation": "Giannoudis A., Clarke K., Zakaria R., Vare\u0161lija D., Farahani M., Rainbow L., Platt-Higgins A., Ruthven S., Brougham K.A., Rudland P.S., et al. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival. Sci. Rep. 2019;9:18518. doi: 10.1038/s41598-019-55084-z.", "ArticleIdList": ["10.1038/s41598-019-55084-z", "PMC6897960", "31811234"]}, {"Citation": "Ebright R.Y., Zachariah M.A., Micalizzi D.S., Wittner B.S., Niederhoffer K.L., Nieman L.T., Chirn B., Wiley D.F., Wesley B., Shaw B., et al. HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nat. Commun. 2020;11:6311. doi: 10.1038/s41467-020-20144-w.", "ArticleIdList": ["10.1038/s41467-020-20144-w", "PMC7725834", "33298946"]}, {"Citation": "Magnussen S.N., Toraskar J., Wilhelm I., Hasko J., Figenschau S.L., Molnar J., Seppola M., Steigen S.E., Steigedal T.S., Hadler-Olsen E., et al. Nephronecin promotes breast cancer brain metastatic colonization via its integrin-binding domains. Sci. Rep. 2020;10:12237. doi: 10.1038/s41598-020-69242-1.", "ArticleIdList": ["10.1038/s41598-020-69242-1", "PMC7376038", "32699247"]}, {"Citation": "Gong X., Hou Z., Endsley M.P., Gronseth E.I., Rarick K.R., Jorns J.M., Yang Q., Du Z., Yan K., Bordas M.L., et al. Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-\u03b22/ANGPTL4 axes. npj Precis. Oncol. 2019;3:24. doi: 10.1038/s41698-019-0094-1.", "ArticleIdList": ["10.1038/s41698-019-0094-1", "PMC6776663", "31602400"]}, {"Citation": "Yu W., Huang W., Yang Y., Qiu R., Zeng Y., Hou Y., Sun G., Shi H., Leng S., Feng D., et al. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer. Cell Death Dis. 2019;10:832. doi: 10.1038/s41419-019-2062-7.", "ArticleIdList": ["10.1038/s41419-019-2062-7", "PMC6828764", "31685800"]}, {"Citation": "Garcia E., Luna I., Persad K.L., Agopsowicz K., Jay D.A., West F.G., Hitt M.M., Persad S. Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition. Sci. Rep. 2021;11:11757. doi: 10.1038/s41598-021-91344-7.", "ArticleIdList": ["10.1038/s41598-021-91344-7", "PMC8175347", "34083676"]}, {"Citation": "Li P., Cao S., Huang Y., Zhang Y., Liu J., Cai X., Zhou L., Li J., Jiang Z., Ding L., et al. A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein. JCDD. 2021;7:198. doi: 10.1038/s41420-021-00580-3.", "ArticleIdList": ["10.1038/s41420-021-00580-3", "PMC8322322", "34326318"]}, {"Citation": "Feng Z., Xia Y., Gao T., Xu F., Lei Q., Peng C., Yang Y., Xue Q., Hu X., Wang Q., et al. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis. Cell Death Dis. 2018;9:1006. doi: 10.1038/s41419-018-1046-3.", "ArticleIdList": ["10.1038/s41419-018-1046-3", "PMC6158270", "30258182"]}, {"Citation": "Yang H., Ren L., Wang Y., Bi X., Li X., Wen M., Zhang Q., Yang Y., Jia Y., Li Y., et al. FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis. Cell Death Dis. 2020;11:851. doi: 10.1038/s41419-020-03053-0.", "ArticleIdList": ["10.1038/s41419-020-03053-0", "PMC7554048", "33051436"]}, {"Citation": "Zhang X., Zhang Z., Zhang Q., Zhang Q., Sun P., Xiang R., Ren G., Yang S. ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM. Cell Death Dis. 2018;9:57. doi: 10.1038/s41419-017-0087-3.", "ArticleIdList": ["10.1038/s41419-017-0087-3", "PMC5833408", "29352223"]}, {"Citation": "Luo H., Zhou Z., Huang S., Ma M., Zhao M., Tang L., Quan Y., Zeng Y., Su L., Kim J., et al. CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1. Cell Death Dis. 2021;12:820. doi: 10.1038/s41419-021-04114-8.", "ArticleIdList": ["10.1038/s41419-021-04114-8", "PMC8405615", "34462429"]}, {"Citation": "Tran Q.H., Hoang D.H., Song M., Choe W., Kang I., Kim S.S., Ha J. Melatonin and doxorubicin synergistically enhance apoptosis via autophagy-dependent reduction of AMPK\u03b11 transcription in human breast cancer cells. Exp. Mol. Med. 2021;53:1413\u20131422. doi: 10.1038/s12276-021-00675-y.", "ArticleIdList": ["10.1038/s12276-021-00675-y", "PMC8492618", "34584194"]}, {"Citation": "Ghebeh H., Al-Khaldi S., Olabi S., Al-Dhfyan A., Al-Mohanna F., Barnawi R., Tulbah A., Al-Tweigeri T., Ajarim D., Al-Alwan M. Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway. Br. J. Cancer. 2014;111:1552\u20131561. doi: 10.1038/bjc.2014.453.", "ArticleIdList": ["10.1038/bjc.2014.453", "PMC4200093", "25117814"]}, {"Citation": "Obayemi J.D., Salifu A.A., Eluu S.C., Uzonwanne V.O., Jusu S.M., Nwazojie C.C., Onyekanne C.E., Ojelabi O., Panye L., Moore C.M., et al. LHRH-Conjugated drugs as targeted therapeutic agents for the specific targeting and localized treatment of triple negative breast cancer. Sci. Rep. 2020;10:8212. doi: 10.1038/s41598-020-64979-1.", "ArticleIdList": ["10.1038/s41598-020-64979-1", "PMC7237454", "32427904"]}, {"Citation": "Bai L.Y., Chiu C.F., Chu P.C., Lin W.Y., Chiu S.J., Weng J.R. A triterpenoid from wild bitter gourd inhibits breast cancer cells. Sci. Rep. 2016;6:22419. doi: 10.1038/srep22419.", "ArticleIdList": ["10.1038/srep22419", "PMC4772478", "26926586"]}, {"Citation": "Iqbal J., Abbasi B.A., Mahmood T., Kanwal S., Ali B., Khalil T. Plant-derived anticancer agents: A green anticancer approach. Asian Pac. J. Trop. Biomed. 2017;3:1\u201323. doi: 10.1016/j.apjtb.2017.10.016.", "ArticleIdList": ["10.1016/j.apjtb.2017.10.016"]}, {"Citation": "Kooti W., Servatyari K., Behzadifar M., Samani M.A., Sadeghi F., Nouri B., Marzouni H.Z. Effective medicinal plant in cancer treatment, Part 2: Review study. J. Evid.-Based Complementary Altern. Med. 2017;22:982\u2013995. doi: 10.1177/2156587217696927.", "ArticleIdList": ["10.1177/2156587217696927", "PMC5871268", "28359161"]}, {"Citation": "Shareef M., Ashraf M.A., Sarfraz M. Natural cures of breast cancer treatment. Saudi Pharm. J. 2016;24:233\u2013240. doi: 10.1016/j.jsps.2016.04.018.", "ArticleIdList": ["10.1016/j.jsps.2016.04.018", "PMC4881189", "27275107"]}, {"Citation": "Driggins S.N., Whalen M., Myles L.E. The inhibitory effect of Echinacea purpurea and Echinacea pallida on BT-549 and natural killer cells. MOJ Cell Sci. Rep. 2017;4:00091."}, {"Citation": "Paredes D.E.E., Garrido J.C., Eutimio M.A.M., Rodr\u00edgue O.P.M., Flores M.E.J., Pichardo C.O. Echinacea Angustifolia DC Extract Induces Apoptosis and Cell Cycle Arrest and Synergizes with Paclitaxel in the MDA-MB-231 and MCF-7 Human Breast Cancer Cell Lines. Nutr. Cancer. 2020;5:1\u201320. doi: 10.1080/01635581.2020.1817956.", "ArticleIdList": ["10.1080/01635581.2020.1817956", "32959676"]}, {"Citation": "Shang A., Cao S.Y., Xu X.Y., Gan R.Y., Tang G.Y., Corke H., Mavumengwana V., Li H.B. Bioactive compounds nad biological functions of Garlic (Allium sativum L.) Foods. 2019;8:246. doi: 10.3390/foods8070246.", "ArticleIdList": ["10.3390/foods8070246", "PMC6678835", "31284512"]}, {"Citation": "Velsankar K., Preethi R., Jeevan Ram P.S., Ramesh M., Sudhahar S. Evaluations of biosynthesized Ag nanoparticles via Allium sativum flower extract in biological applications. Appl. Nanosci. 2020;10:3675\u20133691. doi: 10.1007/s13204-020-01463-2.", "ArticleIdList": ["10.1007/s13204-020-01463-2"]}, {"Citation": "Hemalatha P., Premnath A. Study on silver nanoparticle encapsulated curcumin for anticancer activity. World. J. Pharm. Res. 2016;5:953\u2013958."}, {"Citation": "Minafra L., Porcino N., Bravat\u00e0 V., Gaglio D., Bonanomi M., Amore E., Cammarata F.P., Russo G., Militello C., Savoca G., et al. Radiosensitizing effect of curcuminloaded lipid nanoparticles in breast cancer cells. Sci. Rep. 2019;9:11134. doi: 10.1038/s41598-019-47553-2.", "ArticleIdList": ["10.1038/s41598-019-47553-2", "PMC6668411", "31366901"]}, {"Citation": "Poompavai S., Gowri Sree V. Anti-proliferative efficiency of pulsed electric field treated curcuma longa (Turmeric) extracts on breast cancer cell lines. IETE J. Res. 2020:1\u201315. doi: 10.1080/03772063.2020.1799873.", "ArticleIdList": ["10.1080/03772063.2020.1799873"]}, {"Citation": "Ahmad R., Sirvastava A.N., Khan M.A. Evaluation of in vitro anticancer activity of rhizome of curcuma longa against human breast cancer and Vero cell lines. Int. J. Bot. Studies. 2016;1:1\u20136."}, {"Citation": "Lou C., Zhu Z., Zhao Y., Zhu R., Zhao H. Arctigenin, a liganan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells. Oncol. Rep. 2016;37:179\u2013184. doi: 10.3892/or.2016.5269.", "ArticleIdList": ["10.3892/or.2016.5269", "27878294"]}, {"Citation": "Sun Q., Liu K., Shen X., Jin W., Jiang L., Sheikh S.M., Hu Y., Huang Y., Lappaol F. A Novel Anticancer Agent Isolated from Plant Arctium Lappa, L. Mol. Cancer Ther. 2014;13:49\u201359. doi: 10.1158/1535-7163.MCT-13-0552.", "ArticleIdList": ["10.1158/1535-7163.MCT-13-0552", "24222662"]}, {"Citation": "Ghafari F., Rajabi M.R., Mazoochi T., Taghizadeh M., Nikzad H., Atlasi M.A., Taherian A. Comparing Apoptosis and Necrosis Effects of Arctium Lappa Root Extract and Doxorubicin on MCF7 and MDA-MB-231 Cell Lines. APJCP. 2017;18:795\u2013802.", "ArticleIdList": ["PMC5464502", "28441789"]}, {"Citation": "Li X., Lin Y.Y., Tan J.Y., Liu K.L., Shen X.L., Hu Y.J., Yang R.Y. Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation. Pharm. Biol. 2021;59:619\u2013628. doi: 10.1080/13880209.2021.1923759.", "ArticleIdList": ["10.1080/13880209.2021.1923759", "PMC8143639", "34010589"]}, {"Citation": "Lefojane R.P., Sone B.T., Matinise N., Saleh K., Direko P., Mfengwana P., Mashele S., Maaza M., Sekhoacha M.P. CdO/CdCO3 nanocomposite physical properties and cytotoxicity against selected breast cancer cell lines. Sci. Rep. 2021;11:30. doi: 10.1038/s41598-020-78720-5.", "ArticleIdList": ["10.1038/s41598-020-78720-5", "PMC7794331", "33420103"]}, {"Citation": "Yue G.G.L., Xie S., Lee J.K.M., Kwok H.F., Gao S., Nian Y., Wu X.X., Wong C.K., Qiu M.H., Bik-San Lau C. New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Sci. Rep. 2016;6:35263. doi: 10.1038/srep35263.", "ArticleIdList": ["10.1038/srep35263", "PMC5059658", "27731376"]}, {"Citation": "Kong Y., Li F., Nian Y., Zhou Z., Yang R., Qiu M.H., Chen C. KHF16 is a Leading Structure from Cimicifuga foetida that Suppresses Breast Cancer Partially by Inhibiting the NF-\u03baB Signaling Pathway. Theranostics. 2016;6:875\u2013886. doi: 10.7150/thno.14694.", "ArticleIdList": ["10.7150/thno.14694", "PMC4860895", "27162557"]}, {"Citation": "Nordin N., Yeap S.K., Rahman H.S., Zamberi N.R., Abu N., Mohamad N.E., How C.W., Masarudin M.J., Abdullah R., Alitheen N.B. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cell. Sci. Rep. 2019;9:1614. doi: 10.1038/s41598-018-38214-x.", "ArticleIdList": ["10.1038/s41598-018-38214-x", "PMC6367486", "30733560"]}, {"Citation": "Armas J.P.R., Acevedo J.L.A., Pacheco M.P., Calder\u00f3n O.H., S\u00e1nchez J.M.O., Armas A.R., Calva J., Luna A.C., Vargas J.H. The Essential Oil of Cymbopogon citratus Stapt and Carvacrol: An Approach of the Antitumor Effect on 7,12-Dimethylbenz-[\u03b1]-anthracene (DMBA)-Induced Breast Cancer in Female Rats. Molecules. 2020;25:3284. doi: 10.3390/molecules25143284.", "ArticleIdList": ["10.3390/molecules25143284", "PMC7397214", "32698395"]}, {"Citation": "Thangama R., Sathuvan M., Poongodi A., Suresh V., Pazhanichamy K., Sivasubramanian S., Kanipandian N., Ganesan N., Rengasamy R., Thirumurugan R., et al. Activation of intrinsic apoptotic signaling pathway in cancer cells by Cymbopogon citratus polysaccharide fractions. Carbohydr. Polym. 2014;107:138\u2013150. doi: 10.1016/j.carbpol.2014.02.039.", "ArticleIdList": ["10.1016/j.carbpol.2014.02.039", "24702929"]}, {"Citation": "Qian Mao Q., Yu Xu X., Yu Cao S., You Gan R., Corke H., Beta T., Bin Li H. Bioactive Compounds and Bioactives of Giinger (Zingiber officinale) Foods. 2019;8:185.", "ArticleIdList": ["PMC6616534", "31151279"]}, {"Citation": "Zhao L., Rupji M., Choudhary I., Osan R., Kapoor S., Zhang H.J., Yang C., Aneja R. Efficacy based ginger finger printing reveals potential antiproliferative analytes for triple negative breast cancer. Sci. Rep. 2020;10:19182. doi: 10.1038/s41598-020-75707-0.", "ArticleIdList": ["10.1038/s41598-020-75707-0", "PMC7644756", "33154433"]}, {"Citation": "Elkady A.I., Abuzinadah O.A., Baeshen N.A., Rahmy T.R. Differential Control of Growth, Apoptotic Activity, and Gene Expression in Human Breast Cancer Cells by Extracts Derived from Medicinal Herbs Zingiber officinale. J. Biomed. Biotechnol. 2012;5:614356.", "ArticleIdList": ["PMC3433172", "22969274"]}, {"Citation": "Rahman S., Salehin F., Iqbal A. RETRACTED ARTICLE: In vitro antioxidant and anticancer activity of young Zingiber officinale against human breast carcinoma cell lines. BMC Complementary Altern. Med. 2011;11:76. doi: 10.1186/1472-6882-11-76.", "ArticleIdList": ["10.1186/1472-6882-11-76", "PMC3203256", "21933433"]}, {"Citation": "Alsamri H., Athamneh K., Pintus G., Eid A.H., Iratni R. Pharmacological and Antioxidant Activities of Rhus coriaria L. (Sumac) Antioxidants. 2021;10:73. doi: 10.3390/antiox10010073.", "ArticleIdList": ["10.3390/antiox10010073", "PMC7828031", "33430013"]}, {"Citation": "El Hasasna H., Saleh A., Al Samri H., Athamneh K., Attoub S., Arafat K., Benhalilou N., Alyan S., Viallet J., Al Dhaheri Y., et al. Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NF\u03baB and nitric oxide pathways. Sci. Rep. 2016;6:2114. doi: 10.1038/srep21144.", "ArticleIdList": ["10.1038/srep21144", "PMC4758048", "26888313"]}, {"Citation": "El Hasasna H., Athamneh K., Al Samri H., Karuvantevida N., Al Dhaheri Y., Hisaindee S., Ramadan G., Al Tamimi N., AbuQamar S., Eid A., et al. Rhus coriaria induces senescence and autophagic cell death in breast cancer cells through a mechanism involving p38 and ERK1/2 activation. Sci. Rep. 2015;5:13013. doi: 10.1038/srep13013.", "ArticleIdList": ["10.1038/srep13013", "PMC4532997", "26263881"]}, {"Citation": "Kubatka P., Kello M., Kajo K., Samec M., Liskova A., Jasek K., Koklesova L., Kuruc T., Adamkov M., Smejkal K., et al. Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma. Int. J. Mol. Sci. 2021;22:183. doi: 10.3390/ijms22010183.", "ArticleIdList": ["10.3390/ijms22010183", "PMC7795985", "33375383"]}, {"Citation": "Majumder M., Debnath S., Gajbhiye R.L., Saikia R., Gogoi B., Samanta S.K., Das D.K., Biswas K., Jaisankar P., Mukhopadhyay R. Ricinus communis L. fruit extract inhibits migration/invasion, induces apoptosis in breast cancer cells and arrests tumor progression in vivo. Sci. Rep. 2019;9:14493. doi: 10.1038/s41598-019-50769-x.", "ArticleIdList": ["10.1038/s41598-019-50769-x", "PMC6787038", "31601896"]}, {"Citation": "Abdul W.M., Hajrah N.H., Sabir J.S.M., Al-Garni S.M., Sabir M.J., Kabli S.A., Saini K.S., Bora R.S. Therapeutic role of Ricinus communis L. and its bioactive compounds in disease prevention and treatment. Asian Pac. J. Trop. Med. 2018;11:177\u2013185. doi: 10.4103/1995-7645.228431.", "ArticleIdList": ["10.4103/1995-7645.228431"]}, {"Citation": "Shobha N., Nanda N., Giresha A.S., Manjappa P., Dharmappa K.K., Nagabhushana B.M. Synthesis and characterization of Zinc oxide nanoparticles utilizing seed source of Ricinus communis and study of its antioxidant, antifungal and anticancer activity. Mater. Sci. Eng. 2019;97:842\u2013850. doi: 10.1016/j.msec.2018.12.023.", "ArticleIdList": ["10.1016/j.msec.2018.12.023", "30678976"]}, {"Citation": "Ghate N.B., Das A., Chaudhuri D., Panja S., Mandal N. Sundew plant, a potential source of anti-inflammatory agents, selectively induces G2/M arrest and apoptosis in MCF-7 cells through upregulation of p53 and Bax/Bcl-2 ratio. Cell Death Dis. 2016;2:15062. doi: 10.1038/cddiscovery.2015.62.", "ArticleIdList": ["10.1038/cddiscovery.2015.62", "PMC4979533", "27551490"]}, {"Citation": "Afsar T., Trembley J.H., Salomon C.E., Razak S., Khan M.R., Ahmed K. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways. Sci. Rep. 2016;6:23077. doi: 10.1038/srep23077.", "ArticleIdList": ["10.1038/srep23077", "PMC4791679", "26975752"]}, {"Citation": "Peng Z., Wang Y., Fan J., Lin X., Liu C., Xu Y., Ji W., Yan C., Su C. Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway. Sci. Rep. 2017;7:41254. doi: 10.1038/srep41254.", "ArticleIdList": ["10.1038/srep41254", "PMC5259746", "28117370"]}, {"Citation": "Robinson A., Kumar T.V., Sreedhar E., Naidu V.G.M., Krishna S.R., Babu K.S., Srinivas P.V., Rao J.M. A new sesquiterpene lactone from the roots of Saussurea lappa: Structure\u2013anticancer activity study. Bioorg. Med. Chem. Lett. 2008;18:4015\u20134017. doi: 10.1016/j.bmcl.2008.06.008.", "ArticleIdList": ["10.1016/j.bmcl.2008.06.008", "18579374"]}, {"Citation": "Choi Y.K., Cho S.G., Woo S.M., Yun J.Y., Jo J., Kim W.Y., Shin Y.C., Ko S.G. Saussurea lappa Clarke-Derived Costunolide Prevents TNF\ud835\udefc-Induced Breast Cancer Cell Migration and Invasion by Inhibiting NF-\ud835\udf05B Activity. ECAM. 2013;2013 doi: 10.1155/2013/936257.", "ArticleIdList": ["10.1155/2013/936257", "PMC3755433", "23997800"]}, {"Citation": "Babykutty B., Padikkala J., Sathiadevan P.P., Vijayakurup V., Azis T.K.A., Srinivas P., Gopala S. Apoptosis induction of centella asiatica on human breast cancer cells. Afr. J. Trad. CAM. 2009;6:9\u201316. doi: 10.4314/ajtcam.v6i1.57068.", "ArticleIdList": ["10.4314/ajtcam.v6i1.57068", "PMC2816528", "20162036"]}, {"Citation": "Gou X., Bai H., Liu L., Chen H., Shi Q., Chang L., Ding M., Shi Q., Zhou M., Chen W., et al. Asiatic Acid Interferes with Invasion and Proliferation of Breast Cancer Cells by Inhibiting WAVE3 Activation through PI3K/AKT signaling pathway. Biomed Res. Int. 2020;1874387:12. doi: 10.1155/2020/1874387.", "ArticleIdList": ["10.1155/2020/1874387", "PMC7035546", "32104680"]}, {"Citation": "Pittella F., Dutra R.C., Junior D.D., Lopes M.T.P., Barbosa N.R. Antioxidant and Cytotoxic Activities of Centella asiatica (L) Urb. Int. J. Mol. Sci. 2009;10:3713\u20133721. doi: 10.3390/ijms10093713.", "ArticleIdList": ["10.3390/ijms10093713", "PMC2769141", "19865514"]}, {"Citation": "Xu D., Hua Lin T., Ren Yeh C., Cheng M.A., Min Chen L., Chang C., Yeh S. The Wedelolactone Derivative Inhibits Estrogen Receptor-Mediated Breast, Endometrial, and Ovarian Cancer Cells Growth. BioMed Res. Int. 2014;713263:11. doi: 10.1155/2014/713263.", "ArticleIdList": ["10.1155/2014/713263", "PMC4157183", "25221777"]}, {"Citation": "Arya R.K., Singh A., Yadav N.K., Cheruvu S.H., Hossain Z., Meena S., Maheshwari S., Singh A.K., Shahab U., Sharma C., et al. Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: Novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis. Sci. Rep. 2015;5:18457. doi: 10.1038/srep18457.", "ArticleIdList": ["10.1038/srep18457", "PMC4682077", "26672742"]}, {"Citation": "Huntimer E., Halaweish F., Chase C. Proliferative Activity of Echinacea angustifolia root extracts on cancer cells: Interference with Doxorubicin Cytotoxicity. Chem. Biodivers. 2006;3:695\u2013703. doi: 10.1002/cbdv.200690071.", "ArticleIdList": ["10.1002/cbdv.200690071", "17193302"]}, {"Citation": "A\u0107imovi\u0107 M., \u010cabarkapa I., Cvetkovi\u0107 M., Stankovi\u0107 J., Kiprovski B., Gvozdenac S., Puva\u010da N. Cymbopogon citratus (DC.) Staph: Chemical composition, antimicrobial and antioxidant activities, use in medicinal and cosmetic purpose. J. Agron. Technol. Eng. Manag. 2019;2:344\u2013360."}, {"Citation": "Mao Q.Q., Xu X.Y., Cao S.Y., Gan R.Y., Corke H., Beta T., Li H.B. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe) Foods. 2019;8:185. doi: 10.3390/foods8060185.", "ArticleIdList": ["10.3390/foods8060185", "PMC6616534", "31151279"]}, {"Citation": "Yue S.J., Liu J., Feng W.W., Zhang F.L., Chen J.X., Xin L.T., Peng C., Guan H.S., Wang C.Y., Yan D. System Pharmacology-based dissection of the synergistic mechanism of Huangqi and Huanglian for diabetes mellitus. Front. Pharmacol. 2017;8:694. doi: 10.3389/fphar.2017.00694.", "ArticleIdList": ["10.3389/fphar.2017.00694", "PMC5633780", "29051733"]}, {"Citation": "Huang C., Li R., Shi W., Huang Z. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach. Med. Sci. Monit. 2019;25:5589\u20135593. doi: 10.12659/MSM.918250.", "ArticleIdList": ["10.12659/MSM.918250", "PMC6683728", "31352466"]}, {"Citation": "Wang J.H., Li Y., Yang Y.F., Du J., Zhao M.Q., Lin F. Systems pharmacology dissection of multi-scale mechanisms of action for herbal medicines in treating rheumatoid arthritis. Mol. Pharmacol. 2017;14:7b00505. doi: 10.1021/acs.molpharmaceut.7b00505.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00505", "28771010"]}, {"Citation": "Huang Y., Fang J., Lu W., Wang Z., Wang Q., Hou Y., Jiang X., Reizes O., Lathia J., Nussinov R., et al. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling. Cell Chem. Biol. 2019;26:1143\u20131158. doi: 10.1016/j.chembiol.2019.05.004.", "ArticleIdList": ["10.1016/j.chembiol.2019.05.004", "PMC6697584", "31178408"]}, {"Citation": "Hodaei M., Rahimmalek M., Behbahani M. Anticancer drug discovery from Iranian Chrysanthemum cultivars through system pharmacology exploration and experimental validation. Sci. Rep. 2021;11:11767. doi: 10.1038/s41598-021-91010-y.", "ArticleIdList": ["10.1038/s41598-021-91010-y", "PMC8175602", "34083561"]}, {"Citation": "Sakle N.S., More S.A., Mokale S.N. A network pharmacology-based approach to explore potential targets of Caesalpinia pulcherima: An updated prototype in drug discovery. Sci. Rep. 2020;10:17217. doi: 10.1038/s41598-020-74251-1.", "ArticleIdList": ["10.1038/s41598-020-74251-1", "PMC7560621", "33057155"]}, {"Citation": "Fleisher B., Andrews K., Brown A.A., Ait-Oudhia S. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal A breast cancer. Pharmacol. Res. 2017;2017:1\u201310. doi: 10.1016/j.phrs.2017.07.015.", "ArticleIdList": ["10.1016/j.phrs.2017.07.015", "28735000"]}, {"Citation": "Zhanga S., Gonga C., Ruiz-Martinez A., Wanga H., Davis-Marcisak E., Deshpande A., Popel A.S., Fertig E.J. Integrating single cell sequencing with a spatial quantitative systems pharmacology model spQSP for personalized prediction of triple-negative breast cancer immunotherapy response. Immunoinformatics. 2021;1\u20132:100002. doi: 10.1016/j.immuno.2021.100002.", "ArticleIdList": ["10.1016/j.immuno.2021.100002", "PMC8547770", "34708216"]}, {"Citation": "Chelliah V., Lazarou G., Bhatnagar S., Gibbs J.P., Nijsen M., Ray A., Stoll B., Thompson R.A., Gulati A., Soukharev S., et al. Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm. Clin. Pharmacol. Ther. 2020:1\u201314. doi: 10.1002/cpt.1987.", "ArticleIdList": ["10.1002/cpt.1987", "PMC7983940", "32686076"]}, {"Citation": "Sessions Z., Sanchez-Cruz N., Prieto-Martinez F.D., Lves V.M., Santos H.P., Jr., Muratov E., Tropsha A., Medina-Franco J.L. Recent progress on cheminformatics approaches to epigenetic drug discovery. Drug Discov. 2020;25:2268\u20132276. doi: 10.1016/j.drudis.2020.09.021.", "ArticleIdList": ["10.1016/j.drudis.2020.09.021", "PMC7917005", "33010481"]}, {"Citation": "Grixti J.M., Hagan S., Day P.J., Kell D.B. Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine. Front. Pharmacol. 2017;8:155. doi: 10.3389/fphar.2017.00155.", "ArticleIdList": ["10.3389/fphar.2017.00155", "PMC5366350", "28396636"]}, {"Citation": "Zhu Q., Tao C., Shen F., Chute C.G. Exploring the pharmacogenomics knowledge base (pharm GKB) for repositioning breast cancer drugs by leveraging web ontology language (OWL) and cheminformatics approaches. Pac. Symp. Biocomput. 2014:172\u2013182.", "ArticleIdList": ["PMC3909178", "24297544"]}, {"Citation": "Medina-Franco J.L., Sald\u00edvar-Gonz\u00e1lez F.I. Cheminformatics to Characterize Pharmacologically Active Natural Products. Biomolecules. 2020;10:1566. doi: 10.3390/biom10111566.", "ArticleIdList": ["10.3390/biom10111566", "PMC7698493", "33213003"]}, {"Citation": "Mohanraj K., Karthikeyan B.S., Vivek-Ananth R.P., Chand R.B., Aparna S.R., Mangalapandi P., Samal A. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Sci. Rep. 2018;8:4329. doi: 10.1038/s41598-018-22631-z.", "ArticleIdList": ["10.1038/s41598-018-22631-z", "PMC5847565", "29531263"]}, {"Citation": "Wu Y., Zhang F., Yang K., Fang S., Bu D., Li H., Sun L., Hu H., Gao K., Wang W., et al. SymMap: An integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res. 2018;47:D1110\u2013D1117. doi: 10.1093/nar/gky1021.", "ArticleIdList": ["10.1093/nar/gky1021", "PMC6323958", "30380087"]}, {"Citation": "Venugopalan Nair S.N., Ved D.K., Ravikumar K., Tabassum I.F., Sureshchandra S.T., Somasekhar B.S., Sathya S., Barve V., Naveen S., Payyappalimana U., et al. Indian Medicinal Plants Database (IMPLAD) and Threatened Medicinal Plants of India. In: Rajasekharan P., Wani S., editors. Conservation and Utilization of Threatened Medicinal Plants. Springer; Cham, Switzerland: 2020."}, {"Citation": "Zeng X., Zhang P., Wang Y., Qin C., Chen S., He W., Tao L., Tan Y., Gao D., Wang B., et al. CMAUP: A database of collective molecular activities of useful plants. Nucleic Acids Res. 2018;47:D1118\u2013D1127. doi: 10.1093/nar/gky965.", "ArticleIdList": ["10.1093/nar/gky965", "PMC6324012", "30357356"]}, {"Citation": "Jia C.Y., Li J.Y., Hao G.F., Yang G.F. A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov. 2019;25:248\u2013258. doi: 10.1016/j.drudis.2019.10.014.", "ArticleIdList": ["10.1016/j.drudis.2019.10.014", "31705979"]}, {"Citation": "Keefe L.J., Stoll V.S. Accelerating pharmaceutical structure-guided drug design: A successful model. Drug Discov. 2019;24:318\u2013377. doi: 10.1016/j.drudis.2018.11.008.", "ArticleIdList": ["10.1016/j.drudis.2018.11.008", "30448353"]}, {"Citation": "Ferreira L.L.G., Andricopulo A.D. ADMET modeling approaches in drug discovery. Drug Discov. 2019;24:1157\u20131165. doi: 10.1016/j.drudis.2019.03.015.", "ArticleIdList": ["10.1016/j.drudis.2019.03.015", "30890362"]}, {"Citation": "Fang J., Liu C., Wang Q., Lin P., Cheng F. In silico polypharmacology of natural products. Brief. Bioinform. 2018;19:1153\u20131171. doi: 10.1093/bib/bbx045.", "ArticleIdList": ["10.1093/bib/bbx045", "28460068"]}, {"Citation": "Yang B., Mao J., Gao B., Lu X. Computer-Assisted Drug Virtual Screening Based on the Natural Product Databases. Curr. Pharm. Biotechnol. 2019;20:293\u2013301. doi: 10.2174/1389201020666190328115411.", "ArticleIdList": ["10.2174/1389201020666190328115411", "30919773"]}, {"Citation": "Khan T., Ali M., Khan A., Nisar P., Jan S.A., Afridi S., Shinwari Z.K. Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules. 2020;10:47. doi: 10.3390/biom10010047.", "ArticleIdList": ["10.3390/biom10010047", "PMC7022400", "31892257"]}, {"Citation": "Gaur R., Yadav D.K., Kumar S., Darokar M.P., Khan F., Bhakuni R.S. Molecular modeling based synthesis and evaluation of in vitro anticancer activity of indolyl chalcones. Curr. Top. Med. Chem. 2015;15:1003\u20131012. doi: 10.2174/1568026615666150317222059.", "ArticleIdList": ["10.2174/1568026615666150317222059", "25860176"]}, {"Citation": "Li Y., Wang J., Lin F., Yang Y., Chen S.S. A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines. PLoS ONE. 2017;12:e0169363. doi: 10.1371/journal.pone.0169363.", "ArticleIdList": ["10.1371/journal.pone.0169363", "PMC5222515", "28068355"]}, {"Citation": "Jeyasri R., Muthuramalingam P., Suba V., Ramesh M., Chen J.-T. Bacopa monnieri and Their Bioactive Compounds Inferred Multi-Target Treatment Strategy for Neurological Diseases: A Cheminformatics and System Pharmacology Approach. Biomolecules. 2020;10:536. doi: 10.3390/biom10040536.", "ArticleIdList": ["10.3390/biom10040536", "PMC7225932", "32252235"]}, {"Citation": "Saha P.S., Sarkar S., Jeyasri R., Muthuramalingam P., Ramesh M., Jha S. In vitro propagation, phytochemical and neuropharmacological profiles of Bacopa monnieri (L.) Wettst: A review. Plants. 2020;9:411. doi: 10.3390/plants9040411.", "ArticleIdList": ["10.3390/plants9040411", "PMC7238420", "32224997"]}, {"Citation": "Umadevi M., Sampath Kumar K.P., Bhowmik D., Duraive S. Traditionally Used Anticancer Herbs in India. J. Med. Plants Stud. 2013;1:56\u201374."}, {"Citation": "Mustafa G., Arif R., Atta A., Sharif S., Jamil A. Bioactive Compounds from Medicinal Plants and Their Importance in Drug Discovery in Pakistan. Matrix Sci. Pharma. 2017;1:17\u201326. doi: 10.26480/msp.01.2017.17.26.", "ArticleIdList": ["10.26480/msp.01.2017.17.26"]}, {"Citation": "Subramaniam S., Selvaduray K.R., Radhakrishnan A.K. Bioactive Compounds: Natural Defense Against Cancer? Biomolecules. 2019;9:758. doi: 10.3390/biom9120758.", "ArticleIdList": ["10.3390/biom9120758", "PMC6995630", "31766399"]}, {"Citation": "Baraya Y.S., Kah Keng W., Nik Soriani Y. The Immunomodulatory Potential of Selected Bioactive Plant -Based Compounds in Breast Cancer: A Review. Anticancer Agents Med. Chem. 2017;17:770\u2013783. doi: 10.2174/1871520616666160817111242.", "ArticleIdList": ["10.2174/1871520616666160817111242", "27539316"]}, {"Citation": "Gezici S., Sekeroglu N. Regulation of Micrornas by Natural Products and Bioactive Compounds Obtained from Common Medicinal Plants: Novel Strategy in Cancer Therapy. Indian J. Pharm. Educ. Res. 2017;51:S483\u2013S488. doi: 10.5530/ijper.51.3s.71.", "ArticleIdList": ["10.5530/ijper.51.3s.71"]}, {"Citation": "Zou H., Li Y., Liu X., Wu Z., Li J., Ma Z. Roles of plant-derived bioactive compounds and related microRNAs in cancer therapy. Phytother. Res. 2020;35:1176\u20131186. doi: 10.1002/ptr.6883.", "ArticleIdList": ["10.1002/ptr.6883", "33000538"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "4"}, {"Year": "2021", "Month": "12", "Day": "8"}, {"Year": "2021", "Month": "12", "Day": "9"}, {"Year": "2021", "Month": "12", "Day": "24", "Hour": "1", "Minute": "6"}, {"Year": "2021", "Month": "12", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["34944840", "PMC8699774", "10.3390/cancers13246222", "cancers13246222"]}}], "PubmedBookArticle": []}